Valbiotis SA
EPA:ALVAL.PA
1.354 (EUR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.49 | 4.241 | 0.15 | 0.635 | 0.15 | 0.148 | 2.971 | 0.121 | 0.045 | 0.046 | 0.079 | 0 | -0.037 | 0.04 | 0.123 | 0.162 | 0.162 | 0.162 |
| Cost of Revenue
| 2.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.019 | 0 | 0 | 0 |
| Gross Profit
| -1.57 | 4.241 | 0.15 | 0.635 | 0.15 | 0.148 | 2.971 | 0.121 | 0.045 | 0.046 | 0.079 | 0 | -0.037 | 0.04 | 0.104 | 0.162 | 0.162 | 0.162 |
| Gross Profit Ratio
| -3.204 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0.846 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 2.14 | 5.006 | 4.588 | 3.774 | 4.224 | 1.958 | 2.994 | 1.542 | 1.477 | 1.725 | 2.507 | 1.319 | 1.322 | 0.331 | 0.469 | 0.319 | 0.197 | 0.197 |
| General & Administrative Expenses
| 1.238 | 0.923 | 0.883 | 0.768 | 0.564 | 0.551 | 0.734 | 0.638 | 0.662 | 0.641 | 0.751 | 0.497 | 0.552 | 0.27 | 0.127 | 0.123 | 0 | 0 |
| Selling & Marketing Expenses
| 1.143 | 0.873 | 0.792 | 0.911 | 0.967 | 0.542 | 0.478 | 0.545 | 0.65 | 0.821 | 0.554 | 0.504 | 0.352 | 0.181 | 0.104 | 0.078 | 0.046 | 0.046 |
| SG&A
| 1.65 | 2.032 | 3.299 | 2.337 | 2.305 | 1.671 | 1.632 | 1.336 | 1.459 | 1.485 | 1.458 | 1.067 | 1.069 | 0.451 | 0.231 | 0.201 | -0.133 | -0.133 |
| Other Expenses
| 0 | 0 | -0.023 | -0.017 | -0.014 | -0.056 | -0.076 | 0.076 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 3.79 | 6.044 | 7.91 | 6.128 | 6.543 | 3.685 | 4.702 | 2.802 | 2.938 | 3.21 | 3.061 | 1.902 | 1.996 | 0.374 | 0.39 | 0.18 | 0.064 | 0.064 |
| Operating Income
| -5.36 | -1.802 | -8.246 | -5.809 | -6.885 | -3.986 | -2.263 | -3.151 | -3.362 | -3.617 | -2.874 | -1.914 | -2.066 | -0.335 | -0.397 | -0.18 | -0.143 | -0.143 |
| Operating Income Ratio
| -10.939 | -0.425 | -54.973 | -9.148 | -45.9 | -26.932 | -0.762 | -26.041 | -74.711 | -78.63 | -36.38 | 0 | 55.838 | -8.375 | -3.228 | -1.115 | -0.882 | -0.882 |
| Total Other Income Expenses Net
| -0.09 | -0.118 | -0.084 | -0.065 | 0.495 | -0.055 | 0.443 | -0.116 | -0.033 | 0.288 | -0.15 | -0.029 | -0.005 | -0.037 | 0.001 | -0.017 | -0.006 | -0.006 |
| Income Before Tax
| -5.45 | -1.92 | -8.33 | -5.874 | -6.39 | -4.041 | -1.82 | -3.267 | -3.395 | -3.329 | -3.024 | -1.943 | -2.071 | -0.372 | -0.396 | -0.197 | -0.148 | -0.148 |
| Income Before Tax Ratio
| -11.122 | -0.453 | -55.533 | -9.25 | -42.6 | -27.304 | -0.613 | -27 | -75.444 | -72.37 | -38.278 | 0 | 55.973 | -9.3 | -3.22 | -1.22 | -0.918 | -0.918 |
| Income Tax Expense
| -0.01 | 0.007 | -1.115 | -0.777 | -1.178 | -0.572 | -0.922 | -0.336 | -0.615 | -0.605 | 0 | 0 | 0.005 | 0.005 | 0.003 | 0.003 | 0.006 | 0.006 |
| Net Income
| -5.44 | -1.927 | -7.215 | -5.097 | -5.212 | -3.469 | -0.898 | -2.931 | -2.78 | -2.724 | -3.024 | -1.943 | -2.076 | -0.367 | -0.399 | -0.194 | -0.154 | -0.154 |
| Net Income Ratio
| -11.102 | -0.454 | -48.1 | -8.027 | -34.747 | -23.439 | -0.302 | -24.223 | -61.778 | -59.217 | -38.278 | 0 | 56.108 | -9.175 | -3.244 | -1.201 | -0.954 | -0.954 |
| EPS
| -0.44 | -0.16 | -0.69 | -0.52 | -0.54 | -0.4 | -0.12 | -0.41 | -0.51 | -0.66 | -0.77 | -0.54 | -1.26 | -0.1 | -0.16 | -0.1 | -0.043 | -0.043 |
| EPS Diluted
| -0.44 | -0.16 | -0.69 | -0.52 | -0.54 | -0.4 | -0.12 | -0.41 | -0.51 | -0.66 | -0.77 | -0.54 | -1.26 | -0.1 | -0.16 | -0.1 | -0.043 | -0.043 |
| EBITDA
| -5.155 | -1.661 | -7.76 | -5.493 | -6.393 | -3.537 | -1.731 | -2.681 | -2.893 | -3.164 | -2.674 | -1.857 | -2.009 | -0.323 | -0.551 | -0.011 | -0.137 | -0.137 |
| EBITDA Ratio
| -10.52 | -0.392 | -51.733 | -8.65 | -42.62 | -23.899 | -0.583 | -22.157 | -64.289 | -68.783 | -33.848 | 0 | 54.297 | -8.075 | -4.48 | -0.068 | -0.847 | -0.847 |